NLRP3 and atherosclerosis: These studies have supplied direct evidence that the NLRP3 inflammasome contributes to the progression of atherosclerosis, therefore targeting the NLRP3 inflammasome could potentially be a therapeutic strategy for treating atherosclerosis.